World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
20170
World Ranking
1648
National Ranking
815

Medicine

D-Index
80
Citations
20135
World Ranking
17261
National Ranking
8650

Chien-Fu Hung publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Chien-Fu Hung sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 317 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Chien-Fu Hung D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Chien-Fu Hung sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Chien-Fu Hung is affiliated with Johns Hopkins University in the United States. Their research spans multiple fields including medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Within these areas, Hung's work focuses particularly on immunology, molecular biology, epidemiology, oncology, and infectious diseases.

The scientist has contributed significantly to several main research topics, including immunotherapy and immune responses, cervical cancer and human papillomavirus (HPV) research, cancer immunotherapy and biomarkers, SARS-CoV-2 and COVID-19 research, virus-based gene therapy research, vaccines and immunoinformatics approaches, and COVID-19 clinical research studies.

Hung's recent publications cover important advances in vaccine development and cancer immunotherapy. Notable papers include:

  • "Coronavirus vaccine development: from SARS and MERS to COVID-19" (2020) published in the Journal of Biomedical Science
  • "Cervical Cancer Immunotherapy: Facts and Hopes" (2021) published in Clinical Cancer Research
  • "COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection" (2022) published in the Journal of Biomedical Science
  • "Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody" (2021) published in mBio
  • "Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment" (2020) published in Nature Communications

Frequent co-authors of Chien-Fu Hung include:

  • T.-C. Wu (35 joint publications)
  • Richard B.S. Roden (20 joint publications)
  • Deyin Xing (17 joint publications)
  • Louise Ferrall (16 joint publications)
  • Brandon Lam (14 joint publications)

Hung's work has appeared frequently in several scientific journals, including:

  • Journal of Biomedical Science (8 publications)
  • mBio (4 publications)
  • Cancer Research (4 publications)
  • International Journal of Gynecological Pathology (3 publications)
  • Gynecologic Oncology (3 publications)

Best Publications

  • Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.

    Trevor M. Penning;Michael E. Burczynski;Joseph M. Jez;Chien-Fu Hung

  • Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones.

    Trevor M. Penning;Michael E. Burczynski;Chien Fu Hung;Kirsten D. McCoull

  • Prospects of RNA interference therapy for cancer.

    Pai Si;Lin Yy;Macaes B;Meneshian A

  • Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

    Chien Hung Chen;Tian Li Wang;Chien Fu Hung;Yanqin Yang

  • Coronavirus vaccine development: from SARS and MERS to COVID-19.

    Yen Der Li;Wei Yu Chi;Jun Han Su;Louise Ferrall

  • Cervical cancer immunotherapy: Facts and hopes

    Louise Ferrall;Ken Y. Lin;Richard B.S. Roden;Chien Fu Hung

  • Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

    Wen Fang Cheng;Chien Fu Hung;Chee Yin Chai;Keng Fu Hsu

  • Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

    Cornelia L Trimble;Steven Piantadosi;Patti Gravitt;Brigitte Ronnett

  • DNA vaccine for cancer immunotherapy

    Benjamin Yang;Jessica Jeang;Andrew Yang;T. C. Wu

  • Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

    Meredith L. Stone;Katherine B. Chiappinelli;Huili Li;Lauren M. Murphy

  • COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

    Unknown

  • Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

    Cornelia Trimble;Cheng Tao Lin;Cheng Tao Lin;Chien Fu Hung;Sara Pai

  • Perspectives for therapeutic HPV vaccine development

    Andrew Yang;Emily Farmer;T. C. Wu;Chien Fu Hung;Chien Fu Hung

  • Therapeutic human papillomavirus vaccines: current clinical trials and future directions

    Chien Fu Hung;Barbara Ma;Archana Monie;Shaw Wei Tsen

  • Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

    Tae Woo Kim;Jin Hyup Lee;Chien Fu Hung;Shiwen Peng

  • Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

    Tae Woo Kim;Chien Fu Hung;Morris Ling;Jeremy Juang

  • A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.

    Adriaan D. Bins;Annelies Jorritsma;Monika C. Wolkers;Chien Fu Hung

  • Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.

    Archana Monie;Chien-Fu Hung;Richard S Roden;Tzyy Choou Wu

  • Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response

    Chih Long Chang;Yun Ting Hsu;Chao Chih Wu;Yan Zen Lai

  • Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.

    Chien-Fu Hung;Wen-Fang Cheng;Keng-Fu Hsu;Chee-Yin Chai

  • Antigen‐specific immunotherapy of cervical and ovarian cancer

    Chien Fu Hung;T. C. Wu;Archana Monie;Richard Roden

  • Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.

    Hongxiu Ji;Tian Li Wang;Chien Hung Chen;Chien Hung Chen;Sara I. Pai

Frequent Co-Authors

Tzyy Choou Wu
Tzyy Choou Wu Johns Hopkins University
Richard B.S. Roden
Richard B.S. Roden Johns Hopkins University
Ronald D. Alvarez
Ronald D. Alvarez Vanderbilt University Medical Center
Tian Li Wang
Tian Li Wang Johns Hopkins University
Raphael P. Viscidi
Raphael P. Viscidi Johns Hopkins University
Justin Hanes
Justin Hanes Johns Hopkins University
Drew M. Pardoll
Drew M. Pardoll Johns Hopkins University School of Medicine
Brigitte M. Ronnett
Brigitte M. Ronnett Johns Hopkins University
Elizabeth M. Jaffee
Elizabeth M. Jaffee Johns Hopkins University
J. Marie Hardwick
J. Marie Hardwick Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, pursuing related online degrees can open many doors. Nursing professionals, for instance, may consider a doctorate in nursing salary as a motivating factor to obtain higher qualifications and unlock leadership roles in healthcare and research.

Transitioning from a Family Nurse Practitioner (FNP) to a more specialized field such as acute care can enhance career prospects. Exploring options like the fnp to acute care certification offers a clear pathway for nurses wanting to focus on critical care settings where immunological knowledge is crucial.

Accelerated education options are increasingly popular for busy professionals. The nurse practitioner accelerated program is designed to fast-track qualified candidates into advanced practice roles, allowing them to apply immunology expertise more rapidly within clinical environments.

Additionally, individuals without a nursing background can also enter the healthcare field through dedicated pathways. Top-tier online nursing programs for non nurses offer foundational training that bridges the gap, enabling a smoother transition into nursing and related biomedical careers focused on immunology.

Best Scientists Citing Chien-Fu Hung

Trending Scientists

Recently Published Articles